Dr Mahathir warded in IJN due to lung infection, trial postponed


PETALING JAYA: Former prime minister Tun Dr Mahathir Mohamad was admitted to the National Heart Institute (IJN) on Tuesday (Oct 15), the Kuala Lumpur High Court was told.

Dr Mahathir's lawyer Mior Nor Haidir Suhaimi informed the court that his client was admitted to IJN yesterday afternoon due to a lower respiratory tract infection (LRTI).

"As such, my client has been issued medical leave until Oct 25. I request that today's and tomorrow's hearings be vacated," he said.

Judicial Commissioner Gan Techiong then scheduled the continuation of the trial for Oct 29 and 30, as well as Dec 5, 6, and 9.

The trial will continue on Oct 29.

According to the statement of claim filed on July 20, 2022, Dr Mahathir alleged that Ahmad Zahid, 71, made defamatory remarks against him during an Umno division meeting in Kelana Jaya on July 30, 2017.

The 99-year-old Dr Mahathir believed that the individual referred to by the Umno president, the defendant, in the defamatory statement as "that person", "he", and "Mahathir the son of Iskandar Kutty" clearly referred to him specifically.

As a result, he stated that his standing as a statesman and influential political figure in the eyes of the world has been tarnished.

Dr Mahathir also claimed that Ahmad Zahid's defamatory statement implicitly questioned and cast doubt on his credibility to lead the country and a party that prioritises Malays as a whole.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Nation

Ministry wants public to report bottled cooking oil shortages
Man nabbed for threatening technician with parang at his home
Elderly man injured, car hits baby elephant in Mersing
Authorities seize nearly 2.4 tonnes of imported rice in Johor
KTMB offers 1,248 tickets for special express train to east coast for Aidilfitri
MCMC probes man for uploading fake content on social media
Festive deals for homebuyers
Penang direct flights with China increase to eighth city in Q2 2025
Sapura Energy's RM1.1bil injection includes management changes
Kitingan says has ‘win-win’ seat sharing formula to strengthen GRS

Others Also Read